Romero Angel H, Medina Rafael, Alcala Anamaría, García-Marchan Yael, Núñez-Duran Jorge, Leañez Jacques, Mijoba Ali, Ciangherotti Carlos, Serrano-Martín Xenón, López Simón E
Laboratorio de Química Medicinal y Heterociclos, Departamento de Química, Universidad Simón Bolívar, Valle de Sartenejas, Baruta, Caracas 1080-A, Apartado 89000, Venezuela.
Laboratorio de Bioquímica, Estructura y Función de Proteínas, Área de Salud, Instituto de Estudios Avanzados (IDEA), Caracas, Venezuela.
Eur J Med Chem. 2017 Feb 15;127:606-620. doi: 10.1016/j.ejmech.2017.01.022. Epub 2017 Jan 17.
With the aim to identify a potential drug candidate to treat cutaneous leishmaniasis, a series of 1-phthalazinyl hydrazones were synthesized and tested against Leishmania braziliensis parasite, one of the main responsible of this disease in the world. A structure-activity relationship permitted to identify two phthalazines containing nitroheterocyclic moiety 3l and 3m as promising new lead compounds. These compounds showed a significant antileishmanial activity against promastigote form of L. braziliensis, with EC values in sub-micromolar and nanomolar ranges. The phthalazine 3l also displayed a selective and excellent activity against the clinically relevant intracellular amastigotes form, with a EC value in sub-micromolar range (0.59 μM), without affecting the viability of the host cells. Oxidative stress was identified as the possible mode of action of the most active phthalazine. Considering their significant antileishmanial activity and ease synthesis, the phthalazine containing nitroheterocyclic represents a promising agent against Leishmania braziliensis for the rational design of new leads.
为了确定一种治疗皮肤利什曼病的潜在候选药物,合成了一系列1-酞嗪基腙,并针对巴西利什曼原虫进行了测试,该寄生虫是全球引发这种疾病的主要病原体之一。通过构效关系确定了两种含有硝基杂环部分的酞嗪3l和3m为有前景的新型先导化合物。这些化合物对巴西利什曼原虫的前鞭毛体形式显示出显著的抗利什曼活性,其半数有效浓度(EC)值处于亚微摩尔和纳摩尔范围内。酞嗪3l对临床上相关的细胞内无鞭毛体形式也表现出选择性且优异的活性,其EC值处于亚微摩尔范围(0.59 μM),且不影响宿主细胞的活力。氧化应激被确定为最具活性的酞嗪可能的作用方式。鉴于其显著的抗利什曼活性和易于合成,含有硝基杂环的酞嗪代表了一种有前景的抗巴西利什曼原虫药物,可用于合理设计新的先导化合物。